Search Results

163 results

  1. CORESTA Congress, Kunming, 2018, Agronomy/Phytopathology Groups, AP 32

    Genome-wide identification and functional characterization of senescence-associated genes of the NAC transcription factor family in tobacco

    LI Wei; LI Xiaoxu; CHAO Jiangtao; ZHANG Zenglin; WANG Weifeng; GUO Yongfeng
    Tobacco Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Qingdao, Shandong, P.R. China
    The NAC family is one of the largest families of plant-specific transcription factors. NAC proteins play important regulatory roles in a variety of developmental and stress response processes in plants. Members of the NAC family transcription factors have ...
  2. CORESTA Congress, Kunming, 2018, Agronomy/Phytopathology Groups, AP 39

    Effects of tobacco curing with flower buds in the same bulk-barn on the quality of flue-cured tobacco leaves

    SUN Fushan; ZHOU Ping; WANG Songfeng; ZI Yinyin; ZHENG Furui; GAO Xianhui; ZHANG Ye; LIU Yajun
    Tobacco Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Qingdao, Shandong, P.R. China
    In order to explore new technologies of tobacco curing and flavouring, tobacco leaves were flue-cured with different amounts of fresh tobacco flower buds placed in the curing barn and the results were compared with those of conventional tobacco curing. ...
  3. CORESTA Congress, Kunming, 2018, Agronomy/Phytopathology Groups, APPOST 12

    Degradable residues characterization and possible MRL setting for albendazole, flusilazole and imazalil in tobacco

    JIANG Huatao; YOU Xiangwei; SUI Chengcheng; ZHANG Guangyu; WANG Xiuguo; LI Yiqiang
    Tobacco Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Qingdao, Shandong, P.R. China
    A modified QuEChERS method combined liquid chromatography-tandem triple quadrupole mass spectrometry (HPLC-MS/MS) was developed for three novel pesticides, albendazole, flusilazole and imazalil, which are used for the control of tobacco leaf spot diseases ...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 33 (also presented at TSRC 2018)

    Comparison of potential health risks of combustible, heat-not-burn, and electronic cigarettes

    LIU C.; MARANO K.
    RAI Services Company, Winston-Salem, NC, U.S.A.
    Given U.S. Food and Drug Administration (FDA) regulation of tobacco products via the Family Smoking Prevention and Tobacco Control Act, there is a growing recognition of the need for evidence to assist both applicants and the FDA in making determinations ...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 35

    Different population modeling approaches lead to directionally similar conclusions about the potential for tobacco harm reduction

    BACHAND A.(1); SULSKY S.(1); CURTIN G.(2)
    (1) Ramboll U.S. Corp., Amherst, MA, U.S.A.; (2) RAI Services Co., Winston-Salem, NC, U.S.A.
    There are a number of dynamic population models that can be used to quantify the overall population health effects of beneficial and/or harmful changes in tobacco use patterns. These models can be broadly categorized as either following a single birth ...
  6. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 36 (also presented at TSRC 2018)

    Multi-dimensional tipping point analyses: Assessing simultaneous shifts in tobacco use patterns from a higher to a lower risk product

    BACHAND A.(1); SULSKY S.(1); CURTIN G.(2)
    (1) Ramboll U.S. Corp., Amherst, MA, U.S.A.; (2) RAI Services Co., Winston-Salem, NC, U.S.A.
    The Dynamic Population Modeler (DPM(+1)) employs a birth cohort framework to estimate effects on population mortality if tobacco use patterns shift from a higher- to lower-risk product. DPM(+1) allows for evaluation of changes in use patterns within the ...
  7. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 52 (also presented at TSRC 2018)also presented at TSRC 2018)

    Consumers’ perceptions of disease-specific modified-risk claims are best evaluated in a disease-specific manner

    SHIFFMAN S.(1); CURTIN G.(2)
    (1) Pinney Associates, Pittsburgh, PA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.
    Manufacturers seeking to make claims about modified-risk tobacco products (MRTPs) must assess consumers' perceptions of risk reduction for these products. Claims made for the MRTP and assessment of perceived risk reduction can be global (e.g. &quot ...
  8. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 53 (also presented at TSRC 2018)

    Comparing direct and indirect assessments of perceptions of reduced risk for a modified-risk tobacco product

    SHIFFMAN S.(1); CURTIN G.(2)
    (1) Pinney Associates, Pittsburgh, PA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.
    Manufacturers seeking to make claims about modified-risk tobacco products (MRTPs) must assess consumers' perceptions of absolute and relative risks for these products. We cross-validate data from two methods: (a) indirect assessments based on the ...